A SPAC III Acquisition Stock (NASDAQ: ASPCU)

Latest news for A SPAC III Acquisition (NASDAQ:ASPCU) Stock

A SPAC III Acquisition Corp is a blank check company.

A SPAC III Acquisition Corp

United States Cellular (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.05) by 200 percent. This is a 68.75 percent decrease over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $970.00 million which beat the analyst consensus estimate of $965.87 million by 0.43 percent. This is a 3.00 percent decrease over sales of $1.00 billion the same period last year.

Earnings

Earnings Beats

News

United States Cellular Q4 2024 GAAP EPS $0.05 Beats $(0.05) Estimate, Sales $970.00M Beat $965.87M Estimate

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Repligen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) with a Buy and maintains $180 price target.

Price Target

Reiteration

Analyst Ratings

RGEN

HC Wainwright & Co. Reiterates Buy on Repligen, Maintains $180 Price Target

NIXX

Nixxy Enters Telecommunications And Data Sectors With AI Integration And Software Asset Purchase, Targets $5M Monthly Revenue In Q2

<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">TDS Telecom</td>
<td colspan="1" rowspan="1">2025 Estimated Results</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">Actual Results for the Year Ended December 31, 2024</td>
</tr>
<tr>
<td colspan="1" rowspan="1">(Dollars in millions)</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total operating revenues</td>
<td colspan="1" rowspan="1">$1,030-$1,070</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$1,061</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted OIBDA (Non-GAAP)</td>
<td colspan="1" rowspan="1">$310-$350</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$340</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA&nbsp;(Non-GAAP)</td>
<td colspan="1" rowspan="1">$320-$360</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$350</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital expenditures</td>
<td colspan="1" rowspan="1">$375-$425</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
<td colspan="1" rowspan="1">$324</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Telephone and Data Systems' TDS Telecom Segment Expects FY25 Operating Revenue Of $1.03B-$1.07B Vs $1.06B YoY, Capex Of $320M-$360M Vs $350M YoY

Sunstone Hotel Investors Expects FY25 Adjusted FFO Per Share Of $0.86 - $0.98, Est $0.97

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) with a Buy and maintains $28 price target.

BNTC

HC Wainwright & Co. Reiterates Buy on Benitec Biopharma, Maintains $28 Price Target

NCTY

The9 Forms Joint Venture With Chengdu Qing Cheng Network To Expand Mobile Game Operations In China's Sinking Market

Canaccord Genuity analyst Kyle Mikson maintains Repligen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) with a Hold and raises the price target from $165 to $170.

Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $170

VMAR

Vision Marine Technologies Announced That Its Board Of Directors Has Approved Stock Repurchase Program Authorizing The Repurchase Of Up To 5% Of Company's Issued And Outstanding Common Shares As Of Today

Mizuho analyst Vijay Rakesh maintains Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) with a Neutral and raises the price target from $11 to $13.

RIVN

Mizuho Maintains Neutral on Rivian Automotive, Raises Price Target to $13

Sunstone Hotel Invts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHO#NYSE">SHO</a>) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 14.29 percent. This is a 15.79 percent decrease over earnings of $0.19 per share from the same period last year. The company reported quarterly sales of $214.77 million which beat the analyst consensus estimate of $211.17 million by 1.70 percent. This is a 2.03 percent decrease over sales of $219.22 million the same period last year.

Sunstone Hotel Invts Q4 2024 Adjusted FFO Per Share $0.16 Beats $0.14 Estimate, Sales $214.77M Beat $211.17M Estimate

Earnings Misses

Telephone and Data Q4 2024 Adj. EPS $(0.09), Sales $1.240B Miss $1.254B Estimate

Canaccord Genuity analyst Kyle Rose maintains Insulet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>) with a Buy and raises the price target from $304 to $324.

PODD

Canaccord Genuity Maintains Buy on Insulet, Raises Price Target to $324

HC Wainwright &amp; Co. analyst Yi Chen maintains Bausch &amp; Lomb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLCO#NYSE">BLCO</a>) with a Buy and lowers the price target from $23 to $20.

BLCO

HC Wainwright & Co. Maintains Buy on Bausch & Lomb, Lowers Price Target to $20

Under the terms of the agreement, bluebird stockholders will receive $3.00 per share in cash and a contingent value right per share, entitling the holder to a payment of $6.84 in cash per contingent value right if bluebird's current product portfolio achieves $600 million in net sales in any trailing 12-month period prior to or ending on December 31, 2027, for a potential total value of up to $9.84 per share in cash, subject to the tender of a majority of the outstanding shares of bluebird, receipt of applicable regulatory approvals, and other customary closing conditions.

BLUE

bluebird bio Agrees To Be Acquired By Carlyle And SK Capital For Potential Total Value Of Up To $9.84 Per Share In Cash

Piper Sandler analyst Brent Bracelin reiterates Klaviyo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVYO#NYSE">KVYO</a>) with a Overweight and maintains $53 price target.

KVYO

Piper Sandler Reiterates Overweight on Klaviyo, Maintains $53 Price Target

Piper Sandler analyst Arvind Ramnani maintains Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) with a Overweight and lowers the price target from $237 to $230.

GLOB

Piper Sandler Maintains Overweight on Globant, Lowers Price Target to $230

Pony AI Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) shares&nbsp;are trading&nbsp;higher&nbsp;premarket&nbsp;on Friday after the company launched paid robotaxi services connecting&nbsp;Guangzhou&#8217;s&nbsp;city center with Baiyun International Airpor<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/g43875974/pony-ai-inc-becomes-first-to-offer-robotaxi-operations-connecting-guangzhous-city-center-to-key-tr" rel="noreferrer noopener">t and South Railway Station</a>.
The company said it is the first and only approved to operate on these high-demand routes.
Pony.ai&#8217;s&nbsp;robotaxi service offers residents and tourists a seamless, autonomous travel option.&nbsp;Riders can book via the PonyPilot App, with fares matching standard Guangzhou taxi rates.&nbsp;
James Peng, co-founder and CEO of&nbsp;Pony.ai&nbsp;said,&nbsp;&#8220;By offering autonomous rides from the heart of the city to key transit hubs,&nbsp;we&#8217;re&nbsp;providing practical, real-world services which meet the needs of travellers and city residents alike, solidifying&nbsp;Pony.ai&#8217;stus&nbsp;as a global leader in the large-scale commercialization of autonomous mobility.&#8221;
Notably, Pony.ai has already launched paid robotaxi services at Beijing Daxing International Airport and Beijing South Railway Station.&nbsp;
Expanding in&nbsp;Guangzhou's&nbsp;city center and major transit points marks another key step in its autonomous mobility commercialization.
Last month, Pony.ai&nbsp;become&nbsp;the first company in China to secure approval for&nbsp;robotruck&nbsp;platooning tests on cross-provincial highways&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42996724/pony-ai-inc-becomes-the-first-company-in-china-approved-for-autonomous-truck-platooning-tests" rel="noreferrer noopener">linking Beijing, Tianjin, and Hebei</a>.&nbsp;
Also, in January, Pony.ai disclosed plans to introduce driverless transportation services at&nbsp;Hong Kong International Airport (HKIA),&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42867845/pony-ai-plans-to-provide-driverless-services-at-hong-kong-international-airport-hkia-with-plans-to" rel="noreferrer noopener">one of the&nbsp;world&#8217;s&nbsp;busiest airports</a>.&nbsp;
The company aims to expand its robotaxi services into urban Hong Kong over time.&nbsp;
Price Action: PONY shares are up 4.47% at $18.68 premarket at the last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43829965/black-sesame-emerges-as-dark-horse-in-driving-technology-race" target="_blank" rel="noreferrer noopener">Black Sesame emerges as dark horse in driving technology race</a></li>
</ul>
Photo via Shutterstock.

Equities

Mid Cap

Movers

PONY

Pony AI's Robotaxis Hit Guangzhou's High-Demand Routes: Details

D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNOV#NASDAQ">MNOV</a>) with a Buy and maintains $9 price target.

MNOV

D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

Trading Halt: Halted at 7:25:00 a.m. ET - Trading Halt: Halt News Pending

Commodities

Offerings

Press Releases

A SPAC III Acquisition Corp. Announces Pricing of $55 Million Initial Public Offering

A SPAC III Acquisition Corp. Announces Closing of $55 Million Initial Public Offering

ASPCU

A SPAC III Acquisition

Trading Halt: Halt status updated at 11:00:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

IPOs

Alpha Capital Acquisition Company Shares Open For Trade At $10.35; IPO Priced At $10/Unit

Alpha Capital Acquisition Company Shares Will Open For Quote At 10:35 a.m. EST, Expected To Open For Trade After 10:45 a.m. EST; IPO Priced At $10/Unit

Comments

A SPAC III Acquisition

News

Latest news for A SPAC III Acquisition (NASDAQ:ASPCU) Stock

Friday, November 08, 2024

Friday, February 19, 2021

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga